Trusted Insighthttp://thetrustedinsight.com/2023-05-01T08:31:06.437606-04:00Trusted Insight, the world's largest platform for institutional investors with 40,000 LP investor professionals in 98 countries and territories around the globe. 30,000 institutional investors engage with Trusted Insight each week. They are actively investing in alternative assets, primarily private equity, hedge funds, real estate and private companies. Our users consist of pension funds, endowments, foundations, sovereign wealth funds, family offices, banks and insurance companies. 83% of Trusted Insight users continue to use the platform 6 months after initially signing up. Investors on the platform, on average manage in excess of $5 billion. We are a platform for qualified purchasers, not high net worth investors.
Patient Square Capital Announces Formation Of Elevage Medical Technologies To Partner With Growth-stage Medical Device Companies
2023-05-01T08:31:06.437606-04:00https://www.thetrustedinsight.com/investment-news/patient-square-capital-announces-formation-of-elevage-medical-technologies-to-partner-with-growth-stage-medical-device-companies-20230501038/
$300 million investment commitment from Patient Square Capital MENLO PARK, Calif., May 1, 2023 /PRNewswire/ -- Patient Square Capital ("Patient Square"), a leading health care investment firm, today announced the formation of Elevage Medical Technologies ("Elevage"), a new portfolio...
Gt Medical Technologies Raises $45M In Oversubscribed Series C Financing Led By Gilde Healthcare
2023-03-23T14:11:06.490667-04:00https://www.thetrustedinsight.com/investment-news/gt-medical-technologies-raises-45m-in-oversubscribed-series-c-financing-led-by-gilde-healthcare-20230323417/
Financing Will Help Expand Access to GammaTile® Therapy for Patients with Newly Diagnosed and Recurrent Brain Tumors TEMPE, Ariz., March 23, 2023 /PRNewswire/ -- GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors,...
Sahajanand Medical Tech Files Papers For Rs 1,500-crore Ipo - The Financial Express
2021-09-28T17:01:06.210529-04:00https://www.thetrustedinsight.com/investment-news/sahajanand-medical-tech-files-papers-for-rs-1500-crore-ipo-the-financial-express-20210928238/
The company, which is backed by private equity firms Morgan Stanley Private Equity Asia and Samara Capital, intends to raise the funding through a combination of fresh issue and Offer For Sale (OFS) of shares.
Signifier Medical Technologies Raises $35M In Series D Funding Round To Accelerate Commercialization Of Exciteosa Therapy
2021-07-27T23:41:15.954064-04:00https://www.thetrustedinsight.com/investment-news/signifier-medical-technologies-raises-35m-in-series-d-funding-round-to-accelerate-commercialization-of-exciteosa-therapy-20210727317/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Signifier Medical Technologies Closes $10M Series C Funding Round
2020-09-16T23:01:08.146877-04:00https://www.thetrustedinsight.com/investment-news/signifier-medical-technologies-closes-10m-series-c-funding-round-8vwQrEkiweKeN9SKdAcRNf-20200916813/
BOSTON and LONDON, September 16, 2020-- Signifier Medical Technologies ("Signifier"), an innovator in the sleep disordered breathing market, today announced it has closed a circa $10M Series C funding round led by Alan Howard, VC investor and co-founder of Brevan Howard. The proceeds from this latest successful fundraising will allow Signifier to invest further in its innovative and non-invasive solutions for patients with sleep disordered breathing conditions. The financing round also included participation from James Blair, a career healthcare venture capitalist and Partner/Co-founder of Domain Associates as an additional new investor in Signifier.
Signifier Medical Technologies Closes $10M Series C Funding Round
2020-09-16T10:31:06.371436-04:00https://www.thetrustedinsight.com/investment-news/signifier-medical-technologies-closes-10m-series-c-funding-round-20200916758/
BOSTON and LONDON, Sept. 16, 2020 /PRNewswire/ -- Signifier Medical Technologies ("Signifier"), an innovator in the sleep disordered breathing market, today announced it has closed a circa $10M Series C funding round led by Alan Howard, VC investor and co-founder of Brevan Howard. The...
Orpyx® Medical Technologies Secures $7.6M In Series A Funding
2020-07-08T23:36:09.389902-04:00https://www.thetrustedinsight.com/investment-news/orpyx-medical-technologies-secures-76m-in-series-a-funding-rSQropGNBbV58xNT3swKK5-20200708141/
CALGARY, Canada, July 8, 2020-- Orpyx (orpyx.com), an innovator in digital health therapeutics to prevent diabetic foot complications, today announced the close of a $7.6M Series A investment round. Paddock Capital Inc. led the investment round with participation from existing and new investors, including Aphelion Capital, Thin Air Labs, InterGen Capital, Relentless Venture Fund, ICM Asset Management, Anges Québec, Picante Capital Corp. and Viewpoint Group. The investment brings Orpyx's total funding since inception of the company to $18.5M and will help the company expand its North American commercialization efforts as well as broaden and accelerate technology development.
Orpyx® Medical Technologies Secures $7.6M In Series A Funding
2020-07-08T10:11:06.988093-04:00https://www.thetrustedinsight.com/investment-news/orpyx-medical-technologies-secures-76m-in-series-a-funding-20200708074/
CALGARY, Canada, July 8, 2020 /PRNewswire/ -- Orpyx (orpyx.com), an innovator in digital health therapeutics to prevent diabetic foot complications, today announced the close of a $7.6M Series A investment round. Paddock Capital Inc. led the investment round with participation from...
Chinese Medical Technology Firm Huayin Health Secures $85M In Series C Round – China Money Network
2020-04-08T08:41:05.994307-04:00https://www.thetrustedinsight.com/investment-news/chinese-medical-technology-firm-huayin-health-secures-85m-in-series-c-round-china-money-network-20200408023/
Huayin Health, a Guangzhou-based medical technology firm, has completed a Series C round financing of RMB600 million (US$85 million) led by GL Capital. Qianhai Fund of Funds, Everest Venture Capital, BOCG Investment, Chongqing Venture Capital and In Capital also participated in the round. Established in 2009, Huayin Health is a comprehensive medical technology group engaged […]
Chinese Medical Technology Firm Huayin Health Secures $85M In Series C Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.
Digital Disruption In Insurance - Machine Learning & Automation
2020-01-03T16:10:42.700241-05:00https://www.thetrustedinsight.com/investment-news/digital-disruption-in-insurance-machine-learning-automation-20200103432/
In this panel, a general partner and founders discussed their competitive edge in disrupting the traditional insurance industry, the opportunities in the international markets they operate in; and their ambition for building next-generation insurtech companies. Speakers include Ugur Samut, Co-Founder & CEO, Medigo; Sam Hodges, Co-Founder & CEO, Vouch; Igor Mascarenhas, Co-Founder & CEO, Pier; Kai Stinchcombe, Co-Founder & CEO, True Link Financial; and Karthik Reddy, Co-Founder & Managing Partner, Blume Ventures.
He Jiankui Faces Three Years In Prison For CRISPR Babies
2020-01-02T12:57:48.775431-05:00https://www.thetrustedinsight.com/investment-news/he-jiankui-faces-three-years-in-prison-for-crispr-babies-20200102374/
The Chinese scientist who created the world's first gene-edited children has been sentenced to three years in prison by a Chinese court. He Jiankui, a biophysicist trained at Rice University and Stanford, shocked the world last year with his claim to have created genetically modified humans, twins referred to as Lulu and Nana.
AI Transformation And Innovation In Heathtech, Pharmaceuticals
2019-12-19T11:12:23.201973-05:00https://www.thetrustedinsight.com/investment-news/ai-transformation-and-innovation-in-heathtech-pharmaceuticals-20191219654/
During this panel, a general partner and founders discussed the areas within the health care industry that are ripe for disruption, how they overcome regulatory hurdles building their health-focused startups, and the next steps in scaling their businesses. Speakers include Dr. John Hamer, Managing Partner, DCVC Bio; Sid Viswanathan, Co-Founder and President, Truepill; Jonas Muff, CEO, Merantix Healthcare; and Hilary Coles, Co-Founder and VP of hims and hers.
Meet Truepill Co-Founder Sid Viswanathan: Telemedicine Will Make Medicine 10x Better, Cheaper, Faster
2019-12-06T13:44:12.207305-05:00https://www.thetrustedinsight.com/investment-news/meet-truepill-co-founder-sid-viswanathan-telemedicine-will-make-medicine-10x-better-cheaper-faster-20191206515/
Garry Tan, venture capitalist and co-founder at Initialized Capital, sat down with Sid Viswanathan, co-founder of Truepill. Truepill is an API for all needs for telemedicine. Telemedicine has the potential to bring down costs and make high quality care more accessible for every person on the planet. This video highlights their west coast HQ and fulfillment center out of which they provide pharmacy services for dozens of telemedicine startups and practices large and small, shipping to all 50 states. Here you'll learn how as a founder, you need to choose a problem space that you could want to work on for 10 years or more.
Signifier Medical Technologies Closes An Oversubscribed Series B Funding Round; Driving Innovation In The Sleep Market
2019-06-17T07:16:06.459543-04:00https://www.thetrustedinsight.com/investment-news/signifier-medical-technologies-closes-an-oversubscribed-series-b-funding-round-driving-innovation-in-the-sleep-market-20190617348/
LONDON, June 17, 2019 /PRNewswire/ -- Signifier Medical Technologies, previously known as Snoozeal, an innovator in the sleep disordered breathing market, today announced it has closed an oversubscribed Series B funding, aiming to invest further in R&D and prepare the company for...
Earlens Corporation Raises $87M Led By Kck Medical Technologies Group
2018-10-22T07:01:05.197689-04:00https://www.thetrustedinsight.com/investment-news/earlens-corporation-raises-87m-led-by-kck-medical-technologies-group-20181022885/
MENLO PARK, Calif., Oct. 22, 2018 /PRNewswire/ -- Earlens Corporation, Inc., a privately held medtech company committed to dramatically improving hearing aids, announced today it has completed an $87 million preferred stock financing round led by new investor KCK Ltd., a family investment ...
Providence Medical Technology Secures $25M In Equity Financing
2018-09-21T07:26:07.541100-04:00https://www.thetrustedinsight.com/investment-news/providence-medical-technology-secures-25m-in-equity-financing-20180921135/
PLEASANTON, Calif., September 20, 2018-- Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. Revelation Partners led the round with participation from the private equity investment team at BMO Global Asset Management (EMEA), MVM Life Science Partners, Medvest Capital, and Aphelion Capital. Inclusive of this new investment, Providence has raised a total of $53 million in equity financing since its 2008 inception.
Medical Technology Losing Share Of VC Investments
2017-09-27T09:41:05.245057-04:00https://www.thetrustedinsight.com/investment-news/medical-technology-losing-share-of-venture-investments-20170927894/
Medical technology continues to lose ground when it comes to all U.S. venture capital investment as value-based care takes hold of the U.S. health system and the industry fights to get rid of a device tax, a new report indicates.
Computational Technology for Effective Health Care: Immediate Steps and ... - National Research Council, Division on Engineering and Physical Sciences, Computer Science and Telecommunications Board, Committee on Engaging the Computer Science Research Community in Health Care Informatics - Google Books
2017-07-12T15:29:39.005509-04:00https://www.thetrustedinsight.com/investment-news/computational-technology-for-effective-health-care-immediate-steps-and-national-research-council-division-on-engineering-and-physical-sciences-computer-science-and-telecommunications-board-committee-on-engaging-the-computer-science-research-community-in-20170712976/
https://www.linkedin.com/in/paulsikora/
Happy 150th Birthday Canada
2017-07-01T13:19:29.769381-04:00https://www.thetrustedinsight.com/investment-news/happy-150th-birthday-canada-20170701777/
Cheers from the Team at Black Swan Dexteritas, Tech Hedge Fund. Enjoy and stay safe !!!<br />
<br />
<a href="http://www.blackswandexteritas.com"><span style="color: rgb(51, 51, 51); font-family: sans-serif, Arial, Verdana, 'Trebuchet MS'; font-size: 13px; background-color: rgb(255, 255, 255);">www.blackswandexteritas.com</span></a>
VCs Fund $50M Series C In Knee Osteoarthritis Company
2017-03-18T18:47:13.534222-04:00https://www.thetrustedinsight.com/investment-news/vcs-fund-50m-series-c-in-knee-osteoarthritis-company-20170318636/
Moximed Inc, a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis, has raised $50 million in Series C funding. The company’s investors include Advent Life Sciences, Future Fund, NEA, Morgenthaler Ventures, GBS Venture Partners and Vertex Healthcare.
Cellular Immunotherapy Company Raises $74.1M Series C
2017-03-18T18:37:13.132005-04:00https://www.thetrustedinsight.com/investment-news/cellular-immunotherapy-company-raises-741m-series-c-20170318635/
Cell Medica, a cellular immunotherapy company, has raised 60 million pounds (about $74.1 million) in Series C funding. The investors were Touchstone Innovations, Invesco Perpetual and Woodford Investment.
Why I Invested In Syndicate Room's Hibergene Campaign: Jim Shiggins, Cantor Fitzgerald
2017-03-17T11:03:05.056504-04:00https://www.thetrustedinsight.com/investment-news/why-i-invested-in-syndicate-rooms-hibergene-campaign-jim-shiggins-cantor-fitzgerald-20170317598/
Today Hibergene‘s Series B funding round on SyndicateRoom will successfully close at midnight tonight, having raised at least £5,707,336 with the help of over 53 investors. Funds will be used to support R&D activities to launch three new products in 2017. The Irish medical diagnostics company specializes in the urgent diagnosis of potentially fatal human infectious diseases and has developed what it believes to be a simple, easy to use and low cost solution comprising a compact, fully portable, reusable instrument and a menu of proprietary single use molecular tests.
The Foundry, Lightstone Ventures Launch Medtech Incubator
2017-01-12T11:25:49.585499-05:00https://www.thetrustedinsight.com/investment-news/the-foundry-lightstone-ventures-launch-medtech-incubator-20170112354/
<p data-reactid="5" data-type="text">The Foundry and Lightstone Ventures (LSV) have partnered to launch Foundry SING1, Inc., a medical technology (medtech) incubator that will identify and address unmet clinical needs in Asia.</p>
<p data-reactid="6" data-type="text">Foundry SING1 will identify, incubate and deliver innovative medical device solutions for markets in Asia, leveraging Singapore’s burgeoning medtech ecosystem.</p>
EQT To Sell BSN Medical To SCA
2016-12-19T14:45:51.381582-05:00https://www.thetrustedinsight.com/investment-news/eqt-to-sell-bsn-medical-to-sca-20161219657/
<p>BSN medical, the global integrated medical therapy solutions provider, was today acquired by Svenska Cellulosa Aktiebolaget (“SCA”). To this effect, Private Equity investor EQT VI has entered into an agreement to sell the Company in a transaction valuing BSN medical at EUR 2.7 billion.</p>
<p>During EQT VI’s ownership, BSN medical, specializing in Wound Care/Vascular and Orthopaedics, has undergone significant transformation into a globally leading specialist medical technology firm. The company is posting double-digit growth in specialized businesses and has shifted into high growth product segments and increased its Emerging Markets exposure.</p>
Audax Private Equity Closes Sale Of Laborie Medical Technologies
2016-09-19T11:54:41.287339-04:00https://www.thetrustedinsight.com/investment-news/audax-private-equity-closes-sale-of-laborie-medical-technologies-20160919346/
U.S. private equity firm Audax Private Equity has wrapped up its sale of Laborie Medical Technologies Inc, a Mississauga, Ontario-based provider of medical devices for urological, pelvic health and gastrointestinal applications.
Ten Life Science Startups to Watch in Austin
2016-09-02T14:15:11.285647-04:00https://www.thetrustedinsight.com/investment-news/ten-life-science-startups-to-watch-in-austin-20160902609/
By LAURA LOREK Reporter with Silicon Hills News Austin is home to a small, but growing biotech and medical technology industry with about 200 companies, according to the Greater Austin Chamber of Commerce. That number is sure to skyrocket in coming years as the city feels the full effect of the new Dell Medical School […]The postTen Life Science Startups to Watch in Austinappeared first onSiliconHills.
Cloud Radiotherapy Start-Up Allcure Raises $27M Series A From Two RMB Funds
2016-08-29T17:39:45.974248-04:00https://www.thetrustedinsight.com/investment-news/cloud-radiotherapy-start-up-allcure-raises-27m-series-a-from-two-rmb-funds-20160829397/
Chinese precision cloud radiotherapy start-up Beijing Allcure Medical Technology has raised a RMB180 million (US$27 million) series A funding round from two RMB investment funds, Zhengheci Capital and Lian Fund, Chinese media reported.
4 Years of FundersClub
2016-08-04T18:59:02.020166-04:00https://www.thetrustedinsight.com/investment-news/4-years-of-fundersclub-20160804123/
Institutional investors can learn more at: fcvcadvisors.com
In July 2012, FundersClub launched the world's first online venture capital platform. Our mission? Discover, fund, and support the world's top startups. We are thrilled to share our community's story...
Earlens Announces $51M Financing
2016-06-27T11:43:33.983452-04:00https://www.thetrustedinsight.com/investment-news/earlens-announces-51m-financing-20160627092/
<span style="line-height: 20.8px;">Earlens Corporation, Inc., a privately held medical technology company that has created a revolutionary hearing aid, today announced the first close of </span><span style="line-height: 20.8px;">$51 million</span><span style="line-height: 20.8px;"> in its Series C preferred stock financing led by Vertex Healthcare. </span>
Duke Street Acquires Medi-Globe Corporation
2016-03-16T16:30:31.366353-04:00https://www.thetrustedinsight.com/investment-news/duke-street-acquires-medi-globe-corporation-20160316661/
White & Case LLP has advised London-headquartered mid-market private equity firm Duke Street, as consortium leader, on the acquisition of the Medi-Globe Corporation, a Germany-based medical devices business focused on minimally invasive surgery in gastroenterology and urology.
Exclusive Q&A: Novisi Nirschl, Director At Memorial Sloan-Kettering Cancer Center
2016-03-15T12:00:12.037979-04:00https://www.thetrustedinsight.com/investment-news/novisi-nirschl-director-at-memorial-sloan-kettering-cancer-center-exclusive-qa-20160315581/
Novisi Nirschl is a director of private investments at the investment office of Memorial Sloan-Kettering Cancer Center. Nirschl oversees private equity and real asset investments for the endowment. She graciously spoke with Trusted Insight on January 11, 2016.
TPG-Backed Immucor Acquires Sirona Genomics
2016-03-14T18:30:24.669005-04:00https://www.thetrustedinsight.com/investment-news/tpg-backed-immucor-acquires-sirona-genomics-20160314555/
<a data-entity="{"fcode":"tpgpar","name":"TPG Capital","category":"company"}" style="line-height: 20.8px;">TPG Capital</a><span style="line-height: 20.8px;"> </span><span style="line-height: 20.8px;">-backed </span><a data-entity="{"fcode":"immuc","name":"Immucor","category":"company"}" style="line-height: 20.8px;">Immucor</a><span style="line-height: 20.8px;"> </span><span style="line-height: 20.8px;">Inc., which provides transfusion and transplantation diagnostics for determining patient-donor compatibility, acquired Sirona Genomics, which is developing next-generation sequencing typing applications for the human leukocyte antigen.</span>
Effector Therapeutics Secures $56M Series B Funding
2016-03-13T13:30:15.879587-04:00https://www.thetrustedinsight.com/investment-news/effector-therapeutics-secures-56m-series-b-funding-20160313461/
eFFECTOR Therapeutics, an early-stage company focused on the discovery and development of small molecule cancer therapeutics in San Diego, has secured its Series B financing up to USD 56 million.
Duke Street-Led Consortium Making Moves To Buy Medi-Globe
2016-03-12T12:00:25.812737-05:00https://www.thetrustedinsight.com/investment-news/duke-street-led-consortium-making-moves-to-buy-medi-globe-20160312421/
Duke Street, the mid-market private equity firm, is leading a consortium to acquire Medi-Globe Corporation (Medi-Globe), a Germany-based medical devices business focused on minimally invasive surgery in gastroenterology and urology. The Medi-Globe acquisition is Duke Street’s fifth standalone deal outside a traditional fund structure.
Bone Biologics Completes $5.75M Round Of Financing
2016-03-10T12:30:23.955776-05:00https://www.thetrustedinsight.com/investment-news/bone-biologics-completes-575m-round-of-financing-20160310305/
Bone Biologics, an orthobiologic company focused on regenerative medicine, announced today the completion of a $5.75 million funding round with Musculoskeletal Transplant Foundation, OrthoFix Holdings, Inc. and Hankey Capital, LLC.
Vance Street Buys Maker Of Medical Devices
2016-03-08T11:30:19.921078-05:00https://www.thetrustedinsight.com/investment-news/vance-street-buys-maker-of-medical-devices-20160308151/
Lexington Partners, Neuberger Berman Private Equity, RCP Advisors and Madison Capital Funding co-invested in the deal. Founded in 1968, A&E Medical, of Farmingdale, N.J., primarily focuses on single-use products used in cardiovascular procedures.
Funding Round Brings In $22M For PolyPid
2016-03-06T12:30:20.293436-05:00https://www.thetrustedinsight.com/investment-news/funding-round-brings-in-22m-for-polypid-20160306034/
<span style="line-height: 20.8px;">A Series D funding round has pulled in $22 million for PolyPid, an Israel-based firm developing an antibiotic drug-infused bone substitute for the prevention of postsurgical bacterial infections. The proceeds will be used to support late-stage studies of its lead product, D-Plex.</span>
Venture Capitalists Invest $75M To Launch Forty Seven
2016-03-02T13:00:19.835716-05:00https://www.thetrustedinsight.com/investment-news/venture-capitalists-invest-75m-to-launch-forty-seven-20160302815/
Venture capitalists are investing $75 million to launch Forty Seven Inc., a startup out of Stanford University that has joined a race to defeat cancer by engaging the immune system in the fight against tumors.
Synlogic Nabs $40M, Prepares To Put Modified Microbes Into Patients
2016-02-26T18:00:20.306517-05:00https://www.thetrustedinsight.com/investment-news/synlogic-nabs-40m-prepares-to-put-modified-microbes-into-patients-20160226590/
Synlogic just inked its first partnership, with AbbVie, last week. Today the Cambridge, MA-based startup got the cash needed to get to another first: Tests of its genetically altered microbes in human patients.
Exclusive Q&A: Noah Lewis, Managing Director At GE Ventures
2016-02-18T11:57:57.060962-05:00https://www.thetrustedinsight.com/investment-news/noah-lewis-managing-director-at-ge-ventures-exclusive-qa-20160218177/
Noah Lewis is a managing director at GE Ventures, specializing in healthcare IT, digital health, clinical services and medtech investments across high-growth company lifecycle stages—from series A to growth equity. Mr. Lewis was recently named to Trusted Insight’s ranked list of the Top 30 Healthcare Institutional Investors. He graciously spoke with Trusted Insight on December 18, 2015.
Venture Capital Drives Innovation In Medical Retina Research
2016-02-12T16:00:12.332574-05:00https://www.thetrustedinsight.com/investment-news/venture-capital-drives-innovation-in-medical-retina-research-20160212952/
Robust investment by venture capitalists is making up for stagnant government funding for medical research, particularly in the ophthalmic and biotechnology sectors, a speaker told colleagues here.
Exclusive Q&A: Mark Barnard, Managing Director Of Private Investments At Howard Hughes Medical Institute
2016-02-11T11:13:03.607814-05:00https://www.thetrustedinsight.com/investment-news/mark-barnard-director-of-private-investments-at-howard-hughes-medical-institute-exclusive-qa-20160211880/
<span style="line-height: 20.8px;">Mark Barnard is the managing director of private investments at Howard Hughes Medical Institute's endowment. Mr. Barnard is responsible for the management of a $5 billion private investment portfolio. Mr. Barnard was recently named to Trusted Insight’s ranked list of the </span>Top 30 Healthcare institutional Investors<span style="line-height: 20.8px;">. He graciously spoke with Trusted Insight on Dec. 10, 2015.</span><br />
Evonik Invests In Finnish Medical Device Company Synoste
2016-02-04T17:00:21.734279-05:00https://www.thetrustedinsight.com/investment-news/evonik-invests-in-finnish-medical-device-company-synoste-20160204518/
The investment was made as part of a series A round, together with High-Tech Gründerfonds, two Finnish venture capital funds Finnvera and Lifeline Ventures as well as Finnish business angels.
Charme Turns Attention To Spending After Final Exit On Second Fund
2016-02-03T14:04:51.425437-05:00https://www.thetrustedinsight.com/investment-news/charme-turns-attention-to-spending-after-final-exit-on-second-fund-20160203433/
<span style="line-height: 18.9091px;">Milan-based buyout firm Charme Capital has announced the sale of Bellco, a blood purification company, to listed medical technology company Medtronic. The deal value was undisclosed.</span>
India: Healthcare Focussed PE Fund Quadria To Pick 20% In Concord Biotech
2016-01-19T11:00:20.163977-05:00https://www.thetrustedinsight.com/investment-news/india-healthcare-focussed-pe-fund-quadria-to-pick-20-in-concord-biotech-20160119715/
<div>Quadria Capital, a healthcare-focussed private equity (PE) fund, is set to investRs.500 crore for a 20% stake in drug maker Concord Biotech Ltd, after valuing the company at nearlyRs.2,500 crore, said three people familiar with the development. “The deal closure is expected before the end of this month; (the) final contours are being worked out right now,” said the first person mentioned above requesting anonymity as the discussions are confidential.</div>
Singapore: EDBI co-invests in $45m Series D+ round in US healthcare venture Welltok
2015-12-15T16:28:12.460376-05:00https://www.thetrustedinsight.com/investment-news/singapore-edbi-co-invests-in-45m-series-d-round-in-us-healthcare-venture-welltok-20151215119/
EDBI, the corporate investment arm of the SingaporeEconomic Development Board, has participated alongside Georgian Partners andFlare Capital in the $45-million Series D+ funding round of digital healthcare company Welltok.
Bain Capital Eyes China Fintech And Healthcare Deals
2015-12-15T15:30:36.355879-05:00https://www.thetrustedinsight.com/investment-news/bain-capital-eyes-china-fintech-and-healthcare-deals-20151215095/
The Boston-headquartered private equity firm will start putting its fresh capital to work in the region next year, and is looking for transactions where its experience working with similar companies elsewhere gives it an edge.
Elite Hedge Funds Make Big Moves In These 3 Healthcare Stocks
2015-12-02T13:51:22.375274-05:00https://www.thetrustedinsight.com/investment-news/elite-hedge-funds-make-big-moves-in-these-3-healthcare-stocks-20151202443/
We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space.
SmartZyme nabs $4 mln from OrbiMed
2015-10-27T15:56:15.004664-04:00https://www.thetrustedinsight.com/investment-news/smartzyme-nabs-4-mln-from-orbimed-20151027399/
NESS ZIONA, Israel and NEW YORK–(BUSINESS WIRE)–SmartZyme, a biopharmaceutical company utilizing the proprietary Provolution⢠platform for protein design and engineering of both new and better therapeutics, announces the closing of a $4 million investment by OrbiMed, a leading healthcare investment firm. SmartZyme also named Nissim Darvish, M.D., Ph.D., senior managing director at OrbiMed Israel, and Stephen Squinto, Ph.D., venture partner at OrbiMed, to its board of directors. âOrbiMed is among the worldâs most highly regarded healthcare investors and we are proud to have their backing and vote of confidence in our business,â said Shilo Ben-Zeev, co-founder and chief executive officer...
Investors' Honeymoon With Unicorns Of Silicon Valley Coming To An End
2015-10-23T14:45:15.804652-04:00https://www.thetrustedinsight.com/investment-news/investors-honeymoon-with-unicorns-of-silicon-valley-coming-to-an-end-20151023236/
Privately owned companies valued at $1bn – on paper – are under increased scrutiny as venture capitalists are not seeing fruits of sky-high valuations.
SynCardia files for IPO to raise up to $30 million
2015-09-17T15:19:05.417818-04:00https://www.thetrustedinsight.com/investment-news/syncardia-files-for-ipo-to-raise-up-to-30-million-20150917118/
SynCardia Systems filed for an initial public offering of 2.5 million shares, to raise up to $30 million. The medical technology company, which makes temporary artificial hearts, expects the IPO to price between $10 and $12 a share.
3-D-Printed Tiny Fish Could Be Used For Drug Delivery
2015-09-09T11:48:33.145624-04:00https://www.thetrustedinsight.com/investment-news/3-d-printed-tiny-fish-could-be-used-for-drug-delivery-20150909901/
Scientists at the University of California-San Diego have created so-called microfish that could one day deliver drugs and be used as surgical microrobots. WSJ's Monika Auger reports. Photo: University of California-San Diego.
PillPack raises $50m to help open storefronts and launch mobile app
2015-06-03T17:47:08.900827-04:00https://www.thetrustedinsight.com/investment-news/pillpack-raises-50m-to-help-open-storefronts-and-launch-mobile-app-20150603290/
At first glance, TJ Parker looks a bit more like the guy who you might buy pot from at a Dead concert than the person you’d seek out to purchase your prescription meds....
Novartis, Google Ventures bet on 'robotic pill'
2015-06-01T11:48:58.817828-04:00https://www.thetrustedinsight.com/investment-news/novartis-google-ventures-bet-on-robotic-pill-20150601232/
Rani said it would run feasibility studies over the next 18-24 months to evaluate how selected Novartis biologic medicines can be delivered into the bloodstream using its unique device....
Oscar raises billion-dollar funding round
2015-04-20T11:34:43.788201-04:00https://www.thetrustedinsight.com/investment-news/oscar-raises-billion-dollar-funding-round-20150420821/
Oscar, a New York heath insurance startup, has raised a large new round of funding that values it at $1.5 billion. Led by Founders Fund, the investment firm run by Peter Thiel, as well as Horizon Ventures, Wellington Management Company and Goldman Sachs, the round brings $145 million in new capital to Oscar. The company had previously raised $150 million in funding.
Google Glass Finds Demand in Healthcare Sector
2015-01-12T12:20:39.130388-05:00https://www.thetrustedinsight.com/investment-news/google-glass-finds-demand-in-healthcare-sector-20150112049/
Emergence Capital and DCM backed Augmedix raises $16M Series A for the implementation of Google Glass in doctors' offices
Fewer Women In VC Than In 1999
2014-09-30T13:02:42.150380-04:00https://www.thetrustedinsight.com/investment-news/fewer-women-in-vc-than-in-1999-20140930262/
More than 97% of venture-funded businesses have male CEOs.
Hot Life Science Investor Mandate 1: Family Office Seeking 510k Devices in Eastern US
2014-06-19T15:51:31.318687-04:00https://www.thetrustedinsight.com/investment-news/7979-hot-life-science-investor-mandate-1-family-office-seeking-510k-devices-in-eastern-us-20140619979/
The operational and investment arm of a family office is looking to make equity investments into early stage companies and small mid-market growth companies ranging from $.5 to $1 million.
In Triangle, the $200M venture fund you've never heard about
2014-06-12T14:56:49.348224-04:00https://www.thetrustedinsight.com/investment-news/7840-in-triangle-the-200m-venture-fund-youve-never-heard-about-20140612840/
Editor's note: River Cities Capital, a Midwest-based fund with Raleigh offices is looking for deals in the Triangle. ExitEvent Editor Laura Baverman has the details about the firm's new $200 million ...
Why Medical Instrument and Supply Manufacturers Should Seek Private Equity in 2014
2014-05-13T09:57:51.916003-04:00https://www.thetrustedinsight.com/investment-news/7286-why-medical-instrument-and-supply-manufacturers-should-seek-private-equity-in-2014-20140513286/
The future looks bright for manufacturers in the medical instrument and supply (medical I&S) manufacturing sector. For the most part, manufacturers in the healthcare sector were able to weather the recession well and should see solid growth as the economy recovers. In fact, an IBISWorld report estimates revenues to rise 5.1 percent in 2014.
Health care venture firm Foresite Capital closes $300M fund
2014-04-04T09:39:01.058443-04:00https://www.thetrustedinsight.com/investment-news/6630-health-care-venture-firm-foresite-capital-closes-300m-fund-20140404630/
Just two months after closing a $100 million fund focused on late-stage health care companies, the venture firm has closed a $300 million fund, Foresite Capital Fund II, it announced today....
SAGE Theraputics Nabs $38 Million Series C from OrbiMed Advisors, EcoR1 Capital Management, Foresite Capital Management, Third Rock Ventures, ARCH Venture Partners
2014-03-13T09:53:14.725334-04:00https://www.thetrustedinsight.com/investment-news/6262-sage-theraputics-nabs-38-million-series-c-from-orbimed-advisors-ecor1-capital-management-foresite-capital-management-third-rock-ventures-arch-venture-partners-20140313262/
“We are impressed by SAGE’s focus on rare and orphan CNS diseases,” said Carl Gordon, Ph.D., CFA, general partner at OrbiMed.
Here's where all the stock market action went in the last month
2014-02-12T09:46:19.652448-05:00https://www.thetrustedinsight.com/investment-news/5665-heres-where-all-the-stock-market-action-went-in-the-last-month-20140212665/
Washington & Colorado should be pleased.
GHX Healthcare Exchange is being Bought by PE Firm Thoma Bravo
2014-02-06T12:11:34.462734-05:00https://www.thetrustedinsight.com/investment-news/5531-ghx-healthcare-exchange-is-being-bought-by-pe-firm-thoma-bravo-20140206531/
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app -- it's optimized for your device but there is no need to download....
The Daily Startup: Paul Allen’s Vulcan Capital Backs TrueCar
2013-12-16T06:22:26.681663-05:00https://www.thetrustedinsight.com/investment-news/3785-the-daily-startup-paul-allens-vulcan-capital-backs-truecar-20131216785/
Art by Mike Lucas
In this morning's Web roundup, TrueCar Inc. round up new funding, in a milestone for the company as it recovers from its near collapse last year. HyperBranch Medical Technology Inc. aims to take on pharma giant Covidien PLC in the market for sealants used in cranial surgery.
K.K.R. to Buy Panasonic Health Care Unit for $1.67 Billion
2013-10-02T16:39:21.306599-04:00https://www.thetrustedinsight.com/investment-news/1875-kkr-to-buy-panasonic-health-care-unit-for-167-billion-20131002875/
Kohlberg Kravis Roberts has agreed to buy the health care unit of Panasonic for 165 billion yen, or $1.67 billion, as the Japanese company attempts to streamline its operations after two years of stee...
Wild Basin Investments Focuses on Angel Investing in Austin
2013-09-23T15:55:41.060355-04:00https://www.thetrustedinsight.com/investment-news/1730-wild-basin-investments-focuses-on-angel-investing-in-austin-20130923730/
Wild Basin Investments has an interesting spot in the Austin angel world. A family office, meaning an investment firm run for a particular family, Wild Basin invests in a broad spectrum of early stage companies..
BDC Venture Capital Is Giving $135 Million to Healthcare Tech
2013-09-19T11:58:14.290507-04:00https://www.thetrustedinsight.com/investment-news/1701-bdc-venture-capital-is-giving-135-million-to-healthcare-tech-20130919701/
The BDC's Venture Capital arm announced today that it has allocated $135 million in new capital to direct venture investments in innovative healthcare companies....
TissueTech gets USD 10 million from Ballast Point Ventures, River Cities Capital Funds
2013-08-29T11:56:21.039786-04:00https://www.thetrustedinsight.com/investment-news/tissuetech-gets-usd-10-million-from-ballast-point-ventures-river-cities-capital-funds-20130829471/
TissueTech Inc successfully closed its latest fundraising round. The Florida-based regenerative tissue engineering company said that Ballast Point Ventures and River Cities Capital Funds invested USD...
Toshiba, KKR, Bain to bid for Panasonic healthcare unit: sources
2013-08-29T11:45:37.680141-04:00https://www.thetrustedinsight.com/investment-news/1469-toshiba-kkr-bain-to-bid-for-panasonic-healthcare-unit-sources-20130829469/
Toshiba Corp, U.S. private equity firm Kohlberg Kravis Roberts & Co (KKR) and a consortium including Bain Capital are expected to participate in the final round of bids next week for...
Health app MyFitnessPal raises $18M from Kleiner Perkins, Accel in first round of outside funding -- Tech News and Analysis
2013-08-15T12:01:28.762586-04:00https://www.thetrustedinsight.com/investment-news/1273-health-app-myfitnesspal-raises-18m-from-kleiner-perkins-accel-in-first-round-of-outside-funding-tech-news-and-analysis-20130815273/
Popular diet and exercise tracking app MyFitnessPal has raised $18 million in a Series A round of funding....
Private equity isn't flowing to health care
2013-08-15T11:44:50.637443-04:00https://www.thetrustedinsight.com/investment-news/1267-private-equity-isnt-flowing-to-health-care-20130815267/
Private equity investment in the health care industry was “disappointing” in the second quarter, with $4.1 billion of investment, according to a report out this week...
Fitbit Raises $43 Million From Qualcomm Ventures, SAP Ventures, And SoftBank Capital
2013-08-13T16:39:25.600771-04:00https://www.thetrustedinsight.com/investment-news/1231-fitbit-raises-43-million-from-qualcomm-ventures-sap-ventures-and-softbank-capital-20130813231/
Fitbit, a startup which makes a wide range of digital fitness trackers and health devices, has closed a $43 million funding round and added Softbank Capital...
Private Equity ups investment spend in India's Healthcare sector
2013-07-25T10:56:25.478983-04:00https://www.thetrustedinsight.com/investment-news/965-private-equity-ups-investment-spend-in-indias-healthcare-sector-20130725965/
NEW DELHI: Risk capital funds, including Anand Burman's Asian Healthcare Fund and Singapore and New Delhi-based Quadria Capital, are raising more money to invest in healthcare companies as demand...
Venture capitalists invest more in software, biotech startups - St. Louis Business Journal
2013-07-25T10:49:21.279758-04:00https://www.thetrustedinsight.com/investment-news/964-venture-capitalists-invest-more-in-software-biotech-startups-st-louis-business-journal-20130725964/
Venture capitalists across the country invested more — in dollars and frequency — in software and biotechnology companies during the second quarter of 2013...
VentureHealth’s crowdfunding portal gets blood flowing into ailing life sciences sector | VentureBeat
2013-06-13T10:17:02.661756-04:00https://www.thetrustedinsight.com/investment-news/314-venturehealths-crowdfunding-portal-gets-blood-flowing-into-ailing-life-sciences-sector-venturebeat-20130613314/
VentureHealth has launched its online equity crowdfunding platform for life sciences companies. It provides accredited investors with opportunities to invest in innovative medical technology that ult...
Building Indian Companies for the Global Market - Venture Capital Dispatch - WSJ
2013-05-31T13:14:19.696098-04:00https://www.thetrustedinsight.com/investment-news/123-building-indian-companies-for-the-global-market-venture-capital-dispatch-wsj-20130531123/
Indian companies are quickly becoming global, a trend that both U.S. and Indian investors are exploiting....